findmyKOL
Clinical trialNCT00589784CompletedPhase 2Interventional

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

SponsorMemorial Sloan Kettering Cancer CenterEnrollment50CNS CancerHemangioblastomaIntracranial HemangiopericytomaMeningiomaNeurofibromatosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • Memoral Sloan Kettering Cancer Center

    Basking Ridge, New Jersey, United States

  • Memorial Sloan-Kettering Cancer Center at Commack

    Commack, New York, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • University of Virginia Health Science Center

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2007
Primary completion
31 Oct 2014
Completion
31 Oct 2014
Last update posted
25 Jan 2016
Registered enrollment
50
Registry id
NCT00589784

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.